466 related articles for article (PubMed ID: 11120937)
1. Macrolide resistance conferred by base substitutions in 23S rRNA.
Vester B; Douthwaite S
Antimicrob Agents Chemother; 2001 Jan; 45(1):1-12. PubMed ID: 11120937
[No Abstract] [Full Text] [Related]
2. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America.
Tait-Kamradt A; Davies T; Appelbaum PC; Depardieu F; Courvalin P; Petitpas J; Wondrack L; Walker A; Jacobs MR; Sutcliffe J
Antimicrob Agents Chemother; 2000 Dec; 44(12):3395-401. PubMed ID: 11083646
[TBL] [Abstract][Full Text] [Related]
3. Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics.
Wang G; Taylor DE
Antimicrob Agents Chemother; 1998 Aug; 42(8):1952-8. PubMed ID: 9687389
[TBL] [Abstract][Full Text] [Related]
4. Detection and quantification of macrolide resistance mutations at positions 2058 and 2059 of the 23S rRNA gene by pyrosequencing.
Haanperä M; Huovinen P; Jalava J
Antimicrob Agents Chemother; 2005 Jan; 49(1):457-60. PubMed ID: 15616336
[TBL] [Abstract][Full Text] [Related]
5. Transition mutations in 23S rRNA account for acquired resistance to macrolides in Ureaplasma urealyticum.
Dongya M; Wencheng X; Xiaobo M; Lu W
Microb Drug Resist; 2008 Sep; 14(3):183-6. PubMed ID: 18707551
[TBL] [Abstract][Full Text] [Related]
6. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.
Tait-Kamradt A; Davies T; Cronan M; Jacobs MR; Appelbaum PC; Sutcliffe J
Antimicrob Agents Chemother; 2000 Aug; 44(8):2118-25. PubMed ID: 10898684
[TBL] [Abstract][Full Text] [Related]
7. Macrolide antibiotic interaction and resistance on the bacterial ribosome.
Poehlsgaard J; Douthwaite S
Curr Opin Investig Drugs; 2003 Feb; 4(2):140-8. PubMed ID: 12669373
[TBL] [Abstract][Full Text] [Related]
8. 23S rRNA gene mutations contributing to macrolide resistance in Campylobacter jejuni and Campylobacter coli.
Ladely SR; Meinersmann RJ; Englen MD; Fedorka-Cray PJ; Harrison MA
Foodborne Pathog Dis; 2009; 6(1):91-8. PubMed ID: 19014274
[TBL] [Abstract][Full Text] [Related]
9. Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis.
Pereyre S; Gonzalez P; De Barbeyrac B; Darnige A; Renaudin H; Charron A; Raherison S; Bébéar C; Bébéar CM
Antimicrob Agents Chemother; 2002 Oct; 46(10):3142-50. PubMed ID: 12234836
[TBL] [Abstract][Full Text] [Related]
10. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumoniae.
Depardieu F; Courvalin P
Antimicrob Agents Chemother; 2001 Jan; 45(1):319-23. PubMed ID: 11120988
[TBL] [Abstract][Full Text] [Related]
11. Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA.
Douthwaite S; Hansen LH; Mauvais P
Mol Microbiol; 2000 Apr; 36(1):183-93. PubMed ID: 10760175
[TBL] [Abstract][Full Text] [Related]
12. Streptococcus pyogenes isolates with high-level macrolide resistance and reduced susceptibility to telithromycin associated with 23S rRNA mutations.
Farrell DJ; Shackcloth J; Barbadora KA; Green MD
Antimicrob Agents Chemother; 2006 Feb; 50(2):817-8. PubMed ID: 16436755
[TBL] [Abstract][Full Text] [Related]
13. Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany.
Reinert RR; Wild A; Appelbaum P; Lütticken R; Cil MY; Al-Lahham A
Antimicrob Agents Chemother; 2003 Jul; 47(7):2319-22. PubMed ID: 12821488
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous macrolide resistance and gene conversion in the pneumococcus.
Wolter N; Smith AM; Farrell DJ; Klugman KP
Antimicrob Agents Chemother; 2006 Jan; 50(1):359-61. PubMed ID: 16377711
[TBL] [Abstract][Full Text] [Related]
15. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
[TBL] [Abstract][Full Text] [Related]
16. Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA.
Novotny GW; Jakobsen L; Andersen NM; Poehlsgaard J; Douthwaite S
Antimicrob Agents Chemother; 2004 Oct; 48(10):3677-83. PubMed ID: 15388419
[TBL] [Abstract][Full Text] [Related]
17. Induction of macrolide resistance in Mycoplasma gallisepticum in vitro and its resistance-related mutations within domain V of 23S rRNA.
Wu CM; Wu H; Ning Y; Wang J; Du X; Shen J
FEMS Microbiol Lett; 2005 Jun; 247(2):199-205. PubMed ID: 15936901
[TBL] [Abstract][Full Text] [Related]
18. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.
Farrell DJ; Douthwaite S; Morrissey I; Bakker S; Poehlsgaard J; Jakobsen L; Felmingham D
Antimicrob Agents Chemother; 2003 Jun; 47(6):1777-83. PubMed ID: 12760848
[TBL] [Abstract][Full Text] [Related]
19. Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action.
Xiong L; Kloss P; Douthwaite S; Andersen NM; Swaney S; Shinabarger DL; Mankin AS
J Bacteriol; 2000 Oct; 182(19):5325-31. PubMed ID: 10986233
[TBL] [Abstract][Full Text] [Related]
20. Ribosomal mutations in Arcanobacterium pyogenes confer a unique spectrum of macrolide resistance.
Jost BH; Trinh HT; Songer JG; Billington SJ
Antimicrob Agents Chemother; 2004 Mar; 48(3):1021-3. PubMed ID: 14982799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
